Development of a model system for tick-borne flavivirus persistence in HEK 293T cells

mBio

Volumn 6, Issue 3, 2015, Pages

  Mlera, Luwanika ^a   Offerdahl, Danielle K ^a   Martens, Craig ^a   Porcella, Stephen F ^a   Melik, Wessam ^a   Bloom, Marshall E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; NONSTRUCTURAL PROTEIN 1;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DEFECTIVE INTERFERING PARTICLE; EMBRYO; ENCEPHALITIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LANGAT VIRUS; MENINGITIS; NEXT GENERATION SEQUENCING; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; RNA SEQUENCE; TISSUE INJURY; VIRUS EXPRESSION; VIRUS GENOME; VIRUS PARTICLE; VIRUS STRAIN; EPITHELIUM CELL; GENE DELETION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEK293 CELL LINE; ISOLATION AND PURIFICATION; PHYSIOLOGY; SATELLITE VIRUS; TICK BORNE ENCEPHALITIS VIRUS; VIROLOGY; VIRUS REPLICATION;

IXODIDA; LANGAT VIRUS; MAMMALIA; TICK-BORNE FLAVIVIRUS;

DEFECTIVE VIRUSES; ENCEPHALITIS VIRUSES, TICK-BORNE; EPITHELIAL CELLS; HEK293 CELLS; HUMANS; SEQUENCE DELETION; VIRUS REPLICATION;

EID: 84936971842     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00614-15     Document Type: Article

References (49)

1. Lasala PR, Holbrook M. 2010. Tick-borne flaviviruses. Clin Lab Med 30:221-235. http://dx.doi.org/10.1016/j.cll.2010.01.002.
2. Dobler G. 2010. Zoonotic tick-borne flaviviruses. Vet Microbiol 140: 221-228. http://dx.doi.org/10.1016/j.vetmic.2009.08.024.
3. Gritsun TS, Lashkevich VA, Gould EA. 2003. Tick-borne encephalitis. Antiviral Res 57:129-146. http://dx.doi.org/10.1016/S0166-3542(02)00206-1.
4. Mandl CW. 2005. Steps of the tick-borne encephalitis virus replication cycle that affect neuropathogenesis. Virus Res 111:161-174. http:// dx.doi.org/10.1016/j.virusres.2005.04.007.
5. Smith CE. 1956. A virus resembling Russian Spring-Summer encephalitis virus from an ixodid tick in Malaya. Nature 178:581-582. http:// dx.doi.org/10.1038/178581a0.
6. Gritsun TS, Frolova TV, Zhankov AI, Armesto M, Turner SL, Frolova MP, Pogodina VV, Lashkevich VA, Gould EA. 2003. Characterization of a Siberian virus isolated from a patient with progressive chronic tickborne encephalitis. J Virol 77:25-36. http://dx.doi.org/10.1128/ JVI.77.1.25-36.2003.
7. Haglund M, Forsgren M, Lindh G, Lindquist L. 1996. A 10-year follow-up study of tick-borne encephalitis in the Stockholm area and a review of the literature: need for a vaccination strategy. Scand J Infect Dis 28:217-224. http://dx.doi.org/10.3109/00365549609027160.
8. Haglund M, Günther G. 2003. Tick-borne encephalitis-pathogenesis, clinical course and long-term follow-up. Vaccine 21(Suppl 1):S11-S18. http://dx.doi.org/10.1016/S0264-410X(02)00811-3.
9. Mansfield KL, Johnson N, Phipps LP, Stephenson JR, Fooks AR, Solomon T. 2009. Tick-borne encephalitis virus-a review of an emerging zoonosis. J Gen Virol 90:1781-1794. http://dx.doi.org/10.1099/ vir.0.011437-0.
10. Murray K, Walker C, Herrington E, Lewis JA, McCormick J, Beasley DW, Tesh RB, Fisher-Hoch S. 2010. Persistent infection with West Nile virus years after initial infection. J Infect Dis 201:2-4. http://dx.doi.org/ 10.1086/648731.
11. Birge J, Sonnesyn S. 2012. Powassan virus encephalitis, Minnesota, USA. Emerg Infect Dis 18:1669-1671. http://dx.doi.org/10.3201/ eid1810.120621.
12. Lanteri MC, Lee T-H, Wen L, Kaidarova Z, Bravo MD, Kiely NE, Kamel HT, Tobler LH, Norris PJ, Busch MP. 26 June 2014. West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety. Transfusion 54: 3232-3241. http://dx.doi.org/10.1111/trf.12764.
13. Offerdahl DK, Dorward DW, Hansen BT, Bloom ME. 2012. A threedimensional comparison of tick-borne flavivirus infection in mammalian and tick cell lines. PLoS One 7:e47912. http://dx.doi.org/10.1371/ journal.pone.0047912.
14. Debnath NC, Tiernery R, Sil BK, Wills MR, Barrett AD. 1991. In vitro homotypic and heterotypic interference by defective interfering particles of West Nile virus. J Gen Virol 72:2705-2711. http://dx.doi.org/10.1099/ 0022-1317-72-11-2705.
15. Lancaster MU, Hodgetts SI, Mackenzie JS, Urosevic N. 1998. Characterization of defective viral RNA produced during persistent infection of Vero cells with Murray Valley encephalitis virus. J Virol 72:2474-2482.
16. Schmaljohn C, Blair CD. 1977. Persistent infection of cultured mammalian cells by Japanese encephalitis virus. J Virol 24:580-589.
17. Tonteri E, Jääskeläinen AE, Tikkakoski T, Voutilainen L, Niemimaa J, Henttonen H, Vaheri A, Vapalahti O. 2011. Tick-borne encephalitis virus in wild rodents in winter, Finland, 2008-2009. Emerg Infect Dis 17:72-75. http://dx.doi.org/10.3201/eid1701.100051.
18. Tonry JH, Xiao SY, Siirin M, Chen H, da Rosa AP, Tesh RB. 2005. Persistent shedding of West Nile virus in urine of experimentally infected hamsters. Am J Trop Med Hyg 72:320-324. .
19. Tesh R, Siirin M, Guzman H, Travassos da Rosa A, Wu X, Duan T, Lei H, Nunes M, Xiao S. 2005. Persistent West Nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections. J Infect Dis 192:287-295. http://dx.doi.org/ 10.1086/431153.
20. Tonteri E, Kipar A, Voutilainen L, Vene S, Vaheri A, Vapalahti O, Lundkvist A. 2013. The three subtypes of tick-borne encephalitis virus induce encephalitis in a natural host, the bank vole (Myodes glareolus). PLoS One 8:e81214. http://dx.doi.org/10.1371/journal.pone.0081214.
21. Mlera L, Melik W, Bloom ME. 2014. The role of viral persistence in flavivirus biology. Pathog Dis 71:137-163. http://dx.doi.org/10.1111/2049-632X.12178.
22. Labuda M, Jones LD, Williams T, Danielova V, Nuttall PA. 1993. Efficient transmission of tick-borne encephalitis virus between cofeeding ticks. J Med Entomol 30:295-299. http://dx.doi.org/10.1093/jmedent/ 30.1.295.
23. Labuda M, Nuttall PA, Kozuch O, Elecková E, Williams T, Zuffová E, Sabó A. 1993. Non-viraemic transmission of tick-borne encephalitis virus: a mechanism for arbovirus survival in nature. Experientia 49: 802-805. http://dx.doi.org/10.1007/BF01923553.
24. Mitzel DN, Wolfinbarger JB, Long RD, Masnick M, Best SM, Bloom ME. 2007. Tick-borne flavivirus infection in Ixodes scapularis larvae: development of a novel method for synchronous viral infection of ticks. Virology 365:410-418. http://dx.doi.org/10.1016/j.virol.2007.03.057.
25. Bidet K, Garcia-Blanco MA. 2014. Flaviviral RNAs: weapons and targets in the war between virus and host. Biochem J 462:215-230. http:// dx.doi.org/10.1042/BJ20140456.
26. Lindquist L, Vapalahti O. 2008. Tick-borne encephalitis. Lancet 371: 1861-1871. http://dx.doi.org/10.1016/S0140-6736(08)60800-4.
27. Sips GJ, Wilschut J, Smit JM. 2012. Neuroinvasive flavivirus infections. Rev Med Virol 22:69-87. http://dx.doi.org/10.1002/rmv.712.
28. Huang AS, Baltimore D. 1970. Defective viral particles and viral disease processes. Nature 226:325-327. http://dx.doi.org/10.1038/226325a0.
29. Suss J. 2008. Tick-borne encephalitis in Europe and beyond-the epidemiological situation as of 2007. Euro Surveill 13:p. http:// www.eurosurveillance.org/ViewArticle.aspx?ArticleId_18916.
30. Sullivan BM, Emonet SF, Welch MJ, Lee AM, Campbell KP, de la Torre JC, Oldstone MB. 2011. Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence. Proc Natl Acad Sci U S A 108: 2969-2974. http://dx.doi.org/10.1073/pnas.1019304108.
31. Mitzel DN, Best SM, Masnick MF, Porcella SF, Wolfinbarger JB, Bloom ME. 2008. Identification of genetic determinants of a tick-borne flavivirus associated with host-specific adaptation and pathogenicity. Virology 381: 268-276. http://dx.doi.org/10.1016/j.virol.2008.08.030.
32. Chatel-Chaix L, Bartenschlager R. 2014. Dengue virus and hepatitis C virus-induced replication and assembly compartments: the enemy side-caught in the web. J Virol 88:5907-5911. http://dx.doi.org/10.1128/ JVI.03404-13.
33. Bugrysheva JV, Matveeva VA, Dobrikova EY, Bykovskaya NV, Korobova SA, Bakhvalova VN, Morozova OV. 2001. Tick-borne encephalitis virus NS1 glycoprotein during acute and persistent infection of cells. Virus Res 76:161-169. http://dx.doi.org/10.1016/S0168-1702(01)00274-X.
34. Best SM, Morris KL, Shannon JG, Robertson SJ, Mitzel DN, Park GS, Boer E, Wolfinbarger JB, Bloom ME. 2005. Inhibition of interferonstimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J Virol 79:12828-12839. http:// dx.doi.org/10.1128/JVI.79.20.12828-12839.2005.
35. McLean JE, Wudzinska A, Datan E, Quaglino D, Zakeri Z. 2011. Flavivirus NS4A-induced autophagy protects cells against death and enhances virus replication. J Biol Chem 286:22147-22159. http://dx.doi.org/ 10.1074/jbc.M110.192500.
36. Lee CJ, Liao CL, Lin YL. 2005. Flavivirus activates phosphatidylinositol 3-kinase signaling to block caspase-dependent apoptotic cell death at the early stage of virus infection. J Virol 79:8388-8399. http://dx.doi.org/ 10.1128/JVI.79.13.8388-8399.2005.
37. Bangham CR, Kirkwood TB. 1990. Defective interfering particles: effects in modulating virus growth and persistence. Virology 179:821-826. http://dx.doi.org/10.1016/0042-6822(90)90150-P.
38. López CB. 2014. Defective viral genomes: critical danger signals of viral infections. J Virol 88:8720-8723. http://dx.doi.org/10.1128/ JVI.00707-14.
39. Lazzarini RA, Keene JD, Schubert M. 1981. The origins of defective interfering particles of the negative-strand RNA viruses. Cell 26:145-154. http://dx.doi.org/10.1016/0092-8674(81)90298-1.
40. Akey DL, Brown WC, Dutta S, Konwerski J, Jose J, Jurkiw TJ, DelProposto J, Ogata CM, Skiniotis G, Kuhn RJ, Smith JL. 2014. Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science 343:881-885. http://dx.doi.org/10.1126/ science.1247749.
41. Diamond MS. 2003. Evasion of innate and adaptive immunity by flaviviruses. Immunol Cell Biol 81:196-206. http://dx.doi.org/10.1046/j.1440-1711.2003.01157.x.
42. Lindenbach BD, Rice CM. 1999. Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function. J Virol 73:4611-4621.
43. Lindenbach BD, Rice CM. 1997. Trans-complementation of yellow fever virus NS1 reveals a role in early RNA replication. J Virol 71:9608-9617.
44. Youn S, Li T, McCune BT, Edeling MA, Fremont DH, Cristea IM, Diamond MS. 2012. Evidence for a genetic and physical interaction between nonstructural proteins NS1 and NS4B that modulates replication of West Nile virus. J Virol 86:7360-7371. http://dx.doi.org/10.1128/ JVI.00157-12.
45. Mackenzie JM, Westaway EG. 2001. Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. J Virol 75: 10787-10799. http://dx.doi.org/10.1128/JVI.75.22.10787-10799.2001.
46. Kuno G, Artsob H, Karabatsos N, Tsuchiya KR, Chang GJ. 2001. Genomic sequencing of deer tick virus and phylogeny of Powassan-related viruses of North America. J Trop Med Hyg 65:671-676. http:// www.ajtmh.org/content/65/5/671.long.
47. Westaway EG, Mackenzie JM, Kenney MT, Jones MK, Khromykh AA. 1997. Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virusinduced membrane structures. J Virol 71:6650-6661.
48. Thorvaldsdóttir H, Robinson JT, Mesirov JP. 2013. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 14:178-192. http://dx.doi.org/10.1093/bib/ bbs017.
49. Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP. 2011. Integrative genomics viewer. Nat Biotechnol 29:24-26. http://dx.doi.org/10.1038/nbt.1754.